Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,773 across all filing types
Latest filing 2020-12-03 Declaration of Voting R…
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' by a legal entity (Morgan Stanley) in Evotec SE. It specifies the date the threshold was crossed (26 Nov 2020) and details the breakdown of voting rights attached to shares and instruments. This content directly aligns with regulations concerning the disclosure of significant ownership changes, which falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or potentially Major Shareholding Notification (MRQ). Since the primary focus is the change in voting rights percentage due to acquisition/disposal of instruments, DVA is the most precise fit among the provided options, as it covers voting rights announcements, even if it's not the result of a formal meeting vote, but rather a regulatory disclosure about voting power.
2020-12-03 English
Declaration of Compliance with the German Corporate Governance Code for the year 2020
Governance Information Classification · 98% confidence The document is explicitly titled 'DECLARATION OF COMPLIANCE BY THE MANAGEMENT BOARD AND SUPERVISORY BOARD WITH THE GERMAN CORPORATE GOVERNANCE CODE FOR THE YEAR 2020'. This directly relates to the company's internal rules, board structure, and governance practices as mandated by German law (Section 161 of the German Stock Corporation Act). This aligns perfectly with the definition of Governance Information (CGR). Although it mentions remuneration exceptions, the primary focus and declaration are on overall corporate governance compliance.
2020-12-01 English
Entsprechenserklärung zum Deutschen Corporate Governance Kodex für das Jahr 2020
Governance Information Classification · 99% confidence The document is titled "ENTSPRECHENSERKLÄRUNG ZUM DEUTSCHEN CORPORATE GOVERNANCE KODEX FÜR DAS JAHR 2020 NACH § 161 AKTG" (Statement of Compliance with the German Corporate Governance Code for the year 2020 pursuant to Section 161 of the German Stock Corporation Act). This explicitly indicates that the document details the company's adherence to corporate governance rules and structure for the specified fiscal year. This aligns perfectly with the definition of Governance Information (CGR), which covers internal rules, board structure, and governance practices.
2020-12-01 German
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Evotec SE: Release according to Article 41 of the WpHG' and explicitly states 'Publication of total number of voting rights'. It details a 'Type of capital measure' which is a 'Conditional capital increase' and provides the 'New total number of voting rights'. This content directly relates to changes in the company's capital structure and the resulting voting rights, which aligns best with the 'Capital/Financing Update' category (CAP). Although it involves voting rights, it is a notification about the *total number* resulting from a capital action, not the *results* of a shareholder vote (DVA). Given the focus on capital increase and total rights, CAP is the most precise fit.
2020-11-30 English
DGAP-DD: Evotec SE english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains detailed information regarding a transaction by a person discharging managerial responsibilities ('Dr. Cord Dohrmann, Member of the managing body'). It follows the structure of an insider transaction disclosure, detailing the person, the issuer (Evotec SE), the financial instrument, the nature of the transaction ('Exercise against Cash Settlement (Stock option programme)'), price, volume, and date. This directly corresponds to the definition of Director's Dealing.
2020-11-30 English
EVOTEC AND RAPPTA THERAPEUTICS ENTER DISCOVERY AND DEVELOPMENT PARTNERSHIP FOCUSED ON ONCOLOGY TARGET
Regulatory Filings Classification · 100% confidence The document is a news release dated November 24, 2020, announcing a new multi-year drug development partnership between Evotec SE and Rappta Therapeutics focused on oncology. It details the terms (undisclosed research funding, milestone payments) and provides background on the science and both companies. This type of announcement, detailing a strategic business development or collaboration, does not fit neatly into the specific financial reporting categories (10-K, IR, ER, etc.). Since it is a corporate news item disseminated via DGAP (a service often used for regulatory announcements), and it doesn't fit the specific definitions for M&A (TAR), Financing (CAP), or Director Dealing (DIRS), the most appropriate fallback category is Regulatory Filings (RNS), which serves as the general category for miscellaneous corporate announcements not covered elsewhere.
2020-11-24 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.